Domenico Mallardo

22PUBLICATIONS
173CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical virologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 16, 2026
Immune Checkpoint Inhibitor Data in Metastatic Melanoma with Pre-Existing Autoimmune Disease: A Real World Experience.

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|Jun 11, 2026
How Deeply Can mRNA Vaccines Affect the Responsiveness to Immune Checkpoint Inhibitors Through Changes in the Tumor Microenvironment? Evidence from Melanoma.

|May 27, 2026
Merkel Cell Polyomavirus and DNA Damage Response (DDR): Transcriptional Analysis of DDR Pathways in the Context of Merkel Cell Carcinoma.

|Jul 09, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.

Domenico Mallardo, Mario Fordellone, Michael Bailey

|Jun 13, 2025
Where Reflectance Confocal Microscopy Provides the Greatest Benefit for Diagnosing Skin Cancers: The Experience of the National Cancer Institute of Naples.

Marco Palla, Gerardo Ferrara, Corrado Caracò

Pageof 4

Frequent Collaborators

16 joint publications

Paolo Antonio Ascierto

5 joint publications

Mariaelena Capone

5 joint publications

Ernesta Cavalcanti

4 joint publications

Rosaria De Filippi